In an interview on CNBC’s Mad Money, Kristin Peck said the company is working on products for diabetes and obesity.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZTS:
- Zoetis price target raised to $225 from $220 at BTIG
- Zoetis price target raised to $242 from $230 at Barclays
- Early notable gainers among liquid option names on August 6th
- Morning Movers: Uber and Palantir rise following Q2 results
- Zoetis raises FY24 adjusted EPS view to $5.78-$5.88 from $5.71-$5.81